135 related articles for article (PubMed ID: 38219884)
21. Sanggenon C protects against cardiomyocyte hypoxia injury by increasing autophagy.
Gu Y; Gao L; Chen Y; Xu Z; Yu K; Zhang D; Zhang G; Zhang X
Mol Med Rep; 2017 Dec; 16(6):8130-8136. PubMed ID: 28983604
[TBL] [Abstract][Full Text] [Related]
22. Morus alba L. root decreases melanin synthesis via sphingosine-1-phosphate signaling in B16F10 cells.
Zheng Y; Lee EH; Lee SY; Lee Y; Shin KO; Park K; Kang IJ
J Ethnopharmacol; 2023 Jan; 301():115848. PubMed ID: 36272492
[TBL] [Abstract][Full Text] [Related]
23. [Flavonoids from the leaves of Morus alba L].
Yang Y; Wang HQ; Chen RY
Yao Xue Xue Bao; 2010 Jan; 45(1):77-81. PubMed ID: 21351454
[TBL] [Abstract][Full Text] [Related]
24. Multiple In vitro biological effects of phenolic compounds from Morus alba root bark.
Čulenová M; Sychrová A; Hassan STS; Berchová-Bímová K; Svobodová P; Helclová A; Michnová H; Hošek J; Vasilev H; Suchý P; Kuzminová G; Švajdlenka E; Gajdziok J; Čížek A; Suchý V; Šmejkal K
J Ethnopharmacol; 2020 Feb; 248():112296. PubMed ID: 31610262
[TBL] [Abstract][Full Text] [Related]
25. Moracin M from Morus alba L. is a natural phosphodiesterase-4 inhibitor.
Chen SK; Zhao P; Shao YX; Li Z; Zhang C; Liu P; He X; Luo HB; Hu X
Bioorg Med Chem Lett; 2012 May; 22(9):3261-4. PubMed ID: 22483586
[TBL] [Abstract][Full Text] [Related]
26. The root barks of Morus alba and the flavonoid constituents inhibit airway inflammation.
Lim HJ; Jin HG; Woo ER; Lee SK; Kim HP
J Ethnopharmacol; 2013 Aug; 149(1):169-75. PubMed ID: 23806866
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect and mechanism of action of sanggenon C on human polymorphonuclear leukocyte adhesion to human synovial cells.
Li LC; Shen F; Hou Q; Cheng GF
Acta Pharmacol Sin; 2002 Feb; 23(2):138-42. PubMed ID: 11866874
[TBL] [Abstract][Full Text] [Related]
28. Antioxidant and anti-browning property of 2-arylbenzofuran derivatives from Morus alba Linn root bark.
Paudel P; Seong SH; Wagle A; Min BS; Jung HA; Choi JS
Food Chem; 2020 Mar; 309():125739. PubMed ID: 31787394
[TBL] [Abstract][Full Text] [Related]
29. Bioassay-guided discovery and identification of new potent α-glucosidase inhibitors from Morus alba L. and the interaction mechanism.
Tian LL; Bi YX; Wang C; Zhu K; Xu DF; Zhang H
J Ethnopharmacol; 2024 Mar; 322():117645. PubMed ID: 38147942
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Selective COX-2 Inhibition and In Silico Study of Kuwanon Derivatives Isolated from
Baek SH; Hwang S; Park T; Kwon YJ; Cho M; Park D
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33915826
[TBL] [Abstract][Full Text] [Related]
31. Morusinol extracted from Morus alba induces cell cycle arrest and apoptosis via inhibition of DNA damage response in melanoma by CHK1 degradation through the ubiquitin-proteasome pathway.
Guo L; Dong Z; Zhang X; Yang Y; Hu X; Ji Y; Li C; Wan S; Xu J; Liu C; Zhang Y; Liu L; Shi Y; Wu Z; Liu Y; Cui H
Phytomedicine; 2023 Jun; 114():154765. PubMed ID: 37004403
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic studies, molecular docking, and molecular dynamics simulations of phytochemicals from Morus alba: a multi receptor approach for potential therapeutic agents in colorectal cancer.
Stany B; Mishra S; Rao KVB
Med Oncol; 2024 May; 41(6):156. PubMed ID: 38750377
[TBL] [Abstract][Full Text] [Related]
33. Isolation of cholinesterase-inhibiting flavonoids from Morus lhou.
Kim JY; Lee WS; Kim YS; Curtis-Long MJ; Lee BW; Ryu YB; Park KH
J Agric Food Chem; 2011 May; 59(9):4589-96. PubMed ID: 21434689
[TBL] [Abstract][Full Text] [Related]
34. Sanggenon C induces apoptosis of colon cancer cells via inhibition of NO production, iNOS expression and ROS activation of the mitochondrial pathway.
Chen LD; Liu ZH; Zhang LF; Yao JN; Wang CF
Oncol Rep; 2017 Oct; 38(4):2123-2131. PubMed ID: 28849234
[TBL] [Abstract][Full Text] [Related]
35. Moracin derivatives from Morus Radix as dual BACE1 and cholinesterase inhibitors with antioxidant and anti-glycation capacities.
Seong SH; Ha MT; Min BS; Jung HA; Choi JS
Life Sci; 2018 Oct; 210():20-28. PubMed ID: 30170070
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of PTP1B by farnesylated 2-arylbenzofurans isolated from Morus alba root bark: unraveling the mechanism of inhibition based on in vitro and in silico studies.
Ha MT; Shrestha S; Tran TH; Kim JA; Woo MH; Choi JS; Min BS
Arch Pharm Res; 2020 Sep; 43(9):961-975. PubMed ID: 32978714
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of acute toxicity, genotoxicity and inhibitory effect on acute inflammation of an ethanol extract of Morus alba L. (Moraceae) in mice.
Oliveira AM; Nascimento MF; Ferreira MR; Moura DF; Souza TG; Silva GC; Ramos EH; Paiva PM; Medeiros PL; Silva TG; Soares LA; Chagas CA; Souza IA; Napoleão TH
J Ethnopharmacol; 2016 Dec; 194():162-168. PubMed ID: 27596329
[TBL] [Abstract][Full Text] [Related]
38. Systematic Evaluation of the Mechanisms of Mulberry Leaf (Morus alba Linne) Acting on Diabetes Based on Network Pharmacology and Molecular Docking.
Wu Q; Hu Y
Comb Chem High Throughput Screen; 2021; 24(5):668-682. PubMed ID: 32928080
[TBL] [Abstract][Full Text] [Related]
39. New 2-arylbenzofuran metabolite from cell cultures of Morus alba.
Zhang DW; Tao XY; Yu LY; Dai JG
J Asian Nat Prod Res; 2015; 17(6):683-8. PubMed ID: 26027676
[TBL] [Abstract][Full Text] [Related]
40. Sanggenon C and O inhibit NO production, iNOS expression and NF-κB activation in LPS-induced RAW264.7 cells.
Dat NT; Binh PT; Quynh le TP; Huong HT; Minh CV
Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):84-8. PubMed ID: 21612567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
